BRL 38226,
BRL 38227,
BRL-34915,
BRL-38226,
BRL-38227,
BRL38226,
BRL38227,
Cromakalim,
Cromakalim, (3R-cis)-Isomer,
Cromakalim, (3R-trans)-Isomer,
Cromakalim, (3S-cis)-Isomer,
Cromakalim, (3S-trans)-Isomer,
Cromakalim, (trans)-Isomer,
Lemakalim,
Levcromakalim,
Levcromakalim,
Lemakalim,
Cromakalim,
(-)-Cromakalim,
94535-50-9,
BRL 38227,
Levcromakelim,
BRL-38227,
UNII-RW7PN4BLDJ,
RW7PN4BLDJ,
CHEMBL100,
BRN 3622889,
MLS000069770,
CHEBI:6436,
Cromakalime [French],
Cromakalimum [Latin],
Cromakalim, (3S-trans)-Isomer,
SMR000058880,
94470-67-4,
(3S,4R)-3-Hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-6-chromancarbonitrile,
DSSTox_CID_25677,
DSSTox_RID_81051,
DSSTox_GSID_45677,
Cromakalime,
Cromakalimum,
BRL 34915,
BRL-34915,
2H-1-Benzopyran-6-carbonitrile, 3,4-dihydro-3-hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-, (3S,trans)-,
CAS-94535-50-9,
Cromakalim [INN:BAN],
SR-01000597579,
Cromakalim, trans-Isomer,
C16H18N2O3,
Levanex,
Levcromakalim [USAN:BAN:INN],
Levcromakalim [USAN:INN:BAN],
NCGC00025132-01,
NCGC00025132-02,
2H-1-Benzopyran-6-carbonitrile, 3,4-dihydro-3-hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-, trans-(+-)-,
Opera_ID_416,
AC1L3QBV,
brl34915,
Levcromakalim (USAN/INN),
MLS001077309,
MLS001333994,
SCHEMBL122344,
ZINC1224,
3-Hydroxy-2,2-dimethyl-4-(2-oxo-pyrrolidin-1-yl)-chroman-6-carbonitrile,
DTXSID5045677,
(+-)-trans-3-Hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-6-chromancarbonitrile,
(3S,4R)-3-Hydroxy-2,2-dimethyl-4-(2-oxo-pyrrolidin-1-yl)-chroman-6-carbonitrile,
TVZCRIROJQEVOT-CABCVRRESA-N,
HMS2233P19,
HMS3267D06,
HMS3678K15,
Tox21_110948,
Tox21_113581,
BDBM50010132,
BRL-38266,
AKOS000281031,
Tox21_110948_1,
API0000895,
API0002132,
CS-6950,
NCGC00025132-03,
NCGC00025132-04,
(3S,4R)-3,4-dihydro-3-hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-2H-1-benzopyran-6-carbonitrile,
HY-14255,
LS-39017,
ZB000281,
M&B-44809,
B6711,
B6712,
FT-0630985,
C11697,
D02385,
SR-01000597579-1,
SR-01000597579-2,
BRD-K24526313-001-08-6,
UNII-0G4X367WA3 component TVZCRIROJQEVOT-CABCVRRESA-N,
(3S)-3-hydroxy-2,2-dimethyl-4-(2-oxopyrrolidin-1-yl)-3,4-dihydrochromene-6-carbonitrile,
(3s,4r)-3-hydroxy-2,2-dimethyl-4-(2-oxopyrrolidin-1-yl)chroman-6-carbonitrile,
(3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxopyrrolidin-1-yl)chromane-6-carbonitrile,
1-((3S,4R)-6-Ethynyl-3-hydroxy-2,2-dimethyl-chroman-4-yl)-pyrrolidin-2-one,
3-Hydroxy-2,2-dimethyl-4-(2-oxo-pyrrolidin-1-yl)-chroman-6-carbonitrile (Lemakalim),
3-Hydroxy-2,2-dimethyl-4-(2-oxo-pyrrolidin-1-yl)-chroman-6-carbonitrile(BRL 38227),
3S,4R-3-Hydroxy-2,2-dimethyl-4-(2-oxo-pyrrolidin-1-yl)-chroman-6-carbonitrile,
6-Cyano-3,4-dihydro-2,2-dimethyl-trans-4-(2-oxo-1-pyrrolidinyl)-2H-benzo[b]pyran-3-ol,
trans-6-Cyano-3,4-dihydro-2,2-dimethyl-4-(2-oxopyrrolidinyl)-2H-1-benzopyran-3-ol,
( inverted exclamation markA)-trans-6-Cyano-3,4-dihydro-2,2-dimethyl-4-(2-oxopyrrolidin-1-yl)-2H-1-benzopyran-3-ol,
(3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxopyrrolidin-1-yl)-3,4-dihydrochromene-6-carbonitrile,
2H-1-Benzopyran-6-carbonitrile, 3,4-dihydro-3-hydroxy-2,2-dimethyl-4-(2-oxo-1-pyrrolidinyl)-,(3S-trans)-,
Cromakalim [BAN:INN],
D08DKA,
UNII-0G4X367WA3,
Cromakalim, (trans)-Isomer,
Cromakalim, (3R-cis)-Isomer,
Cromakalim, (3S-cis)-Isomer,
BRL38227,
Cromakalim, (3R-trans)-Isomer,
0G4X367WA3,
BRL38226,
CID93504,
BRL 38226,
BRL-38226,
C16-H18-N2-O3,
D019806,